| Autor: |
den Ley, James J., Hickman, Janet G., Jarratt, Michael T., Stewart, Daniel M., Levy, Sharon F. |
| Zdroj: |
Journal of Cutaneous Medicine and Surgery; January 2001, Vol. 5 Issue: 1 p37-42, 6p |
| Abstrakt: |
Background: Topical clindamycin and benzoyl peroxide have each demonstrated clinical efficacy in the treatment of acne vulgaris. When used in tandem, they promise greater efficacy than either individual agent through their antibacterial and anti-inflammatory effects.Objective: To determine the efficacy and safety of combination benzoyl peroxide/clindamycin compared with benzoyl peroxide or benzoyl peroxide/erythromycin in the treatment of acne.Methods: In this randomized, 10-week, multicenter, single-blind trial, 492 patients with moderate to moderately severe acne were treated twice daily with 5% benzoyl peroxide/1% clindamycin, 5% benzoyl peroxide, or 5% benzoyl peroxide/3% erythromycin and assessed every 2 weeks.Results: Compared with benzoyl peroxide, benzoyl peroxide/clindamycin demonstrated significantly greater reductions in inflammatory lesions (p= 0.04) and significantly greater overall improvement as assessed by physicians (p ? 0.04) and patients (p= 0.001). Benzoyl peroxide/clindamycin demonstrated a nonsignificant trend for greater efficacy compared to benzoyl peroxide/erythromycin. Dry skin was the most frequent (?7.3%) adverse event with all three therapies.Conclusion: Benzoyl peroxide/clindamycin demonstrated improved efficacy and similar tolerability to benzoyl peroxide used alone and was similar to benzoyl peroxide/erythromycin, making this combination product an effective alternative antimicrobial therapy for acne. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full text from SpringerLink